# Clinical Trial to Evaluate the Reduction of Cardiovascular Risk

> **NCT04114916** · NA · COMPLETED · sponsor: **Universidad Católica San Antonio de Murcia** · enrollment: 100 (actual)

## Conditions studied

- Cholesterol

## Interventions

- **DIETARY_SUPPLEMENT:** Apigenin, luteonin, grapefruit extract and citrolive
- **DIETARY_SUPPLEMENT:** maltodextrina

## Key facts

- **NCT ID:** NCT04114916
- **Lead sponsor:** Universidad Católica San Antonio de Murcia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2018-12-22
- **Final completion:** 2018-12-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04114916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04114916, "Clinical Trial to Evaluate the Reduction of Cardiovascular Risk". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04114916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
